![]() |
市場調查報告書
商品編碼
1813394
2032 年創傷器材市場預測:按產品類型、材料類型、手術部位、最終用戶和地區進行的全球分析Trauma Devices Market Forecasts to 2032 - Global Analysis By Product Type, Material Type, Surgical Site, End User and By Geography |
根據 Stratistics MRC 的數據,全球創傷設備市場預計在 2025 年達到 97.2 億美元,到 2032 年將達到 143.3 億美元,預測期內複合年成長率為 5.7%。
創傷器械是用於治療骨折、脫位和軟組織損傷等損傷的醫療器械和植入,包括外固定裝置、鋼板、螺絲和髓內釘。交通事故和運動傷害的增加,以及老齡化人口易患骨質疏鬆相關骨折,推動了市場需求的成長。生物相容性材料、微創技術和客製化植入的不斷創新正在塑造市場。
根據世界衛生組織 (WHO) 的數據,道路交通事故每年造成約 119 萬人死亡和 2,000 萬至 5,000 萬人非致命傷害,支持了全球對創傷照護和整形外科器械的需求。
交通事故和運動傷害增加
在全球範圍內,高強度道路交通事故和運動相關傷害的發生率不斷上升,是創傷器材市場的主要驅動力。這些事故通常會導致複合性骨折和嚴重的肌肉骨骼損傷,需要即時使用先進的內外固定裝置進行手術干預。在新興經濟體中,接觸性運動的參與度不斷提高以及機動車輛使用量的增加進一步刺激了這項需求。此外,日益增強的健康意識也促使人們尋求先進的醫療手段,從而推動了先進創傷治療方案的採用,並透過手術量的持續成長直接促進了市場擴張。
治療和設備成本高
鎖定加壓鋼板和生物可吸收植入等先進創傷器械的高昂價格,以及手術的整體成本,嚴重限制了市場的發展。這些高昂的成本給醫療保健支付方和患者帶來了沉重的經濟負擔,尤其是在對價格敏感的新興經濟體和保險覆蓋有限的人群中。這可能導致治療延誤、採用更便宜的替代方案,甚至避免治療。此外,嚴格的報銷政策和醫院系統內部的預算限制進一步限制了高價創新創傷器材的市場滲透率和採用率。
微創創傷手術的發展
微創手術(MIS)採用專門的髓內釘和骨螺釘系統,與傳統開放性手術相比具有顯著優勢,包括減少失血、縮小切口、降低感染風險以及加快患者康復時間。這一趨勢推動了對專為MIS設計的新型器械和導航技術的需求。此外,隨著外科醫生水平的提高和患者對門診手術的偏好日益成長,這些先進技術的採用預計將開闢新的收益來源並擴大潛在市場。
醫療改革給價格帶來壓力
政府措施和監管機構正在擴大實施成本控制措施,包括競爭性競標、基於價值的採購和嚴格的價格上限機制。此外,集團採購組織 (GPO) 的影響力日益增強,利用其批量購買力來協商大幅折扣,加劇了定價壓力。這種環境迫使製造商以低利潤率銷售,這可能會限制對下一代創傷器械研發的投資,並使新產品的商業性可行性受到質疑。
新冠疫情最初嚴重擾亂了創傷器材市場。為了優先應對疫情並節省資源,擇期手術被推遲,導致手術量大幅下降。供應鏈中斷也導致必需器械和原料間歇性短缺。然而,市場表現出韌性,因為創傷手術(佔危及生命的損傷急救手術的大多數)仍在繼續,儘管速度有所放緩。被壓抑的需求和推遲的手術隨後刺激了強勁的復甦階段,在最初的停擺期後恢復了市場的成長軌跡。
內固定器材市場預計將成為預測期內最大的市場
內固定器材領域預計將在預測期內佔據最大的市場佔有率,這得益於其在為各種複雜骨折提供穩定內固定方面的卓越效果。這些器械包括鋼板、螺絲、髓內釘和U形釘,能夠實現解剖復位,促進骨直接癒合,並允許術後即時活動。它們廣泛應用於長骨、髖部和關節骨折的治療,加上生物可吸收複合材料等材料的不斷進步,鞏固了其作為現代整形外科創傷外科治療標準的主導地位。
預計下肢部分在預測期內的複合年成長率最高
由於髖骨、股骨、膝骨、脛骨和踝骨等部位的損傷發生率較高,下肢骨折領域預計將在預測期內出現最高成長率。這是因為這些肢體承受著巨大的機械負荷,使其更容易因意外和跌倒而受傷。此外,骨質疏鬆症和肥胖症的發生率上升也增加了該解剖部位骨折的風險。專為複雜下肢骨折設計的髓內釘系統和鎖定鋼板的技術進步,進一步推動了該領域的應用和成長。
預計北美將在預測期內佔據最大的市場佔有率,這得益於其完善的醫療基礎設施、高昂的醫療費用以及醫療保險和私人保險公司優惠的報銷政策。該地區運動傷害和道路交通事故的發生率較高,老年人口眾多,且易患骨質疏鬆症和脆性骨折。此外,大型設備製造商的強大影響力以及先進技術創傷設備的廣泛採用也持續推動該地區市場收益。
預計亞太地區將在預測期內實現最高的複合年成長率。這一加速成長得益於醫療保健可近性的改善、醫療旅遊業的蓬勃發展、私人醫療產業的擴張以及政府對醫療基礎設施的持續投資。此外,該地區龐大的患者群體、不斷上升的道路交通事故以及人們對先進治療方案日益成長的認知也是關鍵的成長動力。微創手術技術的日益普及以及跨國公司在這些新興經濟體中日益壯大的存在,也大大促進了該市場的快速擴張。
According to Stratistics MRC, the Global Trauma Devices Market is accounted for $9.72 billion in 2025 and is expected to reach $14.33 billion by 2032 growing at a CAGR of 5.7% during the forecast period. Trauma devices are medical instruments and implants used for treating injuries such as fractures, dislocations, and soft tissue damage. They include external fixators, plates, screws, and intramedullary nails. Market demand is rising due to increasing road accidents, sports injuries, and an aging population prone to osteoporosis-related fractures. Continuous innovations in biocompatible materials, minimally invasive techniques, and customized implants are shaping the market.
According to the World Health Organization, road traffic crashes cause about 1.19 million deaths annually and 20-50 million non fatal injuries, sustaining global demand for trauma care and orthopedic devices.
Rising road accidents and sports injuries
The increasing global incidence of high-impact road traffic accidents and sports-related injuries is a primary driver for the trauma devices market. These events often result in complex fractures and severe musculoskeletal damage, necessitating immediate surgical intervention with advanced internal and external fixation devices. The growing participation in contact sports and expanding vehicular usage in developing economies exacerbate this demand. Furthermore, rising health awareness encourages individuals to seek advanced treatment, thereby propelling the adoption of sophisticated trauma care solutions and directly contributing to market expansion through consistent volume growth in procedural volumes.
High treatment and device costs
The significant costs associated with advanced trauma devices, such as locking compression plates and bioabsorbable implants, alongside the overall surgical expenditure, act as a major market restraint. These high costs create a substantial financial burden for healthcare payers and patients, particularly in price-sensitive emerging economies and for individuals with limited insurance coverage. Consequently, this can lead to delayed treatment, the adoption of alternative cheaper solutions, or even treatment avoidance. Moreover, stringent reimbursement policies and budget constraints within hospital systems further limit market penetration and adoption rates of premium-priced innovative trauma devices.
Growth in minimally invasive trauma surgeries
MIS procedures, facilitated by specialized intramedullary nails and bone screw systems, offer considerable benefits over traditional open surgery, including reduced blood loss, smaller incisions, lower infection risk, and faster patient recovery times. This trend is driving demand for novel, designed-for-MIS instrumentation and navigational technologies. Additionally, as surgeon proficiency increases and patient preference for outpatient procedures grows, the adoption of these advanced techniques is expected to unlock new revenue streams and expand the addressable market.
Pricing pressures from healthcare reforms
Government initiatives and regulatory bodies are increasingly implementing cost-containment measures, including competitive bidding, value-based procurement, and stringent price cap mechanisms. Additionally, the growing influence of group purchasing organizations (GPOs) amplifies pricing pressures by leveraging their bulk purchasing power to negotiate significant discounts. This environment forces manufacturers to operate on thinner margins, potentially stifling investment in research and development for next-generation trauma devices and challenging the commercial viability of new product launches.
The COVID-19 pandemic initially disrupted the trauma devices market significantly. Elective procedures were postponed to prioritize pandemic response and conserve resources, leading to a notable decline in procedural volumes. Supply chain disruptions also caused intermittent shortages of essential devices and raw materials. However, the market demonstrated resilience as trauma surgeries, being largely emergency procedures for life-threatening injuries, continued albeit at a moderated pace. The pent-up demand and backlog of delayed surgeries subsequently fueled a strong recovery phase, restoring market growth trajectories post the initial lockdown periods.
The internal fixators segment is expected to be the largest during the forecast period
The internal fixators segment is expected to account for the largest market share during the forecast period due to its superior efficacy in providing stable internal fixation for a wide spectrum of complex fractures. These devices, including plates, screws, intramedullary nails, and staples, enable anatomical reduction, promote direct bone healing, and allow for immediate postoperative mobilization, which is a critical clinical advantage. Their extensive application in treating fractures of long bones, hips, and joints, coupled with continuous material advancements like bioresorbable composites, solidifies their dominant position as the standard of care in modern orthopedic trauma surgery.
The lower extremities segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the lower extremities segment is predicted to witness the highest growth rate, driven by the high prevalence of injuries to the hip, femur, knee, tibia, and ankle. This is attributable to the high mechanical loads borne by these limbs, making them susceptible to injuries from accidents and falls. Moreover, the rising incidence of osteoporosis and obesity increases the risk of fractures in this anatomical region. Technological advancements in intramedullary nailing systems and locking plates specifically designed for complex lower limb fractures are further accelerating the adoption and growth of this segment.
During the forecast period, the North America region is expected to hold the largest market share, attributed to its well-established healthcare infrastructure, high healthcare expenditure, and favorable reimbursement policies through Medicare and private insurers. The region has a high prevalence of sports-related injuries, road accidents, and a significant geriatric population prone to osteoporosis and fragility fractures. Furthermore, the strong presence of leading device manufacturers and a rapid adoption rate for technologically advanced trauma products consistently drive market revenue in this region.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This accelerated growth is fueled by improving healthcare access, rising medical tourism, expanding private healthcare sectors, and increasing government investments in healthcare infrastructure. Additionally, the region's large patient population, growing incidences of road accidents, and rising awareness about advanced treatment options are key growth drivers. The increasing adoption of minimally invasive surgical techniques and the expanding presence of global players in these emerging economies are also significantly contributing to this rapid market expansion.
Key players in the market
Some of the key players in Trauma Devices Market include Johnson & Johnson, Stryker, Zimmer Biomet, Smith & Nephew, Medtronic, Globus Medical, Orthofix, B. Braun, Enovis, Integra LifeSciences, CONMED, MicroPort Scientific Corporation, Arthrex, Acumed, Cardinal Health, Wright Medical Group, Medacta International, and Paragon 28.
In September 2025, Cardinal Health at-Home Solutions opened a Texas distribution center and announced plans for a new California site, expanding logistics capacity that underpins supply of medical products to trauma-care settings.
In June 2025, Arthrex launched Synergy Power, a battery-powered instrument system designed for broad orthopaedic use including trauma and distal extremities procedures.
In June 2025, Cardinal Health announced the U.S. launch of the Kendall DL Multi System for continuous patient monitoring, reflecting ongoing development in its medical products segment that supports peri-trauma care pathways.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.